1. Home
  2. AFYA vs MRVI Comparison

AFYA vs MRVI Comparison

Compare AFYA & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

SELL

Current Price

$14.82

Market Cap

1.3B

Sector

Real Estate

ML Signal

SELL

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$7.08

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AFYA
MRVI
Founded
1999
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
AFYA
MRVI
Price
$14.82
$7.08
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
★ $17.65
$7.83
AVG Volume (30 Days)
460.2K
★ 2.3M
Earning Date
11-11-2026
11-05-2026
Dividend Yield
★ 4.58%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ N/A
N/A
Revenue
N/A
★ $185,743,000.00
Revenue This Year
$7.66
$14.01
Revenue Next Year
$7.06
$6.20
P/E Ratio
$9.30
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$11.62
$2.55
52 Week High
$16.16
$9.42

Technical Indicators

Market Signals
Indicator
AFYA
MRVI
Relative Strength Index (RSI) 65.97 45.42
Support Level $13.43 $5.54
Resistance Level $14.84 $7.60
Average True Range (ATR) 0.50 0.42
MACD 0.27 -0.06
Stochastic Oscillator 99.38 7.82

Price Performance

Historical Comparison
AFYA
MRVI

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: